Collagen Type V anticorps
-
- Antigène Voir toutes Collagen Type V (COL5) Anticorps
- Collagen Type V (COL5) (Collagen, Type V (COL5))
-
Reactivité
- Humain
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Collagen Type V est non-conjugé
-
Application
- ELISA
- Specificité
- Reacts with conformational determinants on type V collagen Referenced species reactivities include - Human 2,5,6,11,13,14,17,23-26 Chicken 4 Porcine 1,5,8 Mouse 3,12,20 Cuttlefish 27 Rabbit 9,15 Rat 5,7,10,16 Equine 19,21,22 Tree Shrew 18 Canine 5 Guinea Pig 15
- Réactivité croisée (Details)
- Exhibits < 10 % cross reactivity with collagen type II, III, IV, V and VI. The antibody has not been tested for reactivity with other ECM proteins (e.g., laminin, fibronectin).
- Attributs du produit
- Goat Anti-Type V Collagen-UNLB
- Purification
- Purification Method: Affinity chromatography on type V collagen covalently linked to agarose.
- Isotype
- IgG
- Top Product
- Discover our top product COL5 Anticorps primaire
-
-
- Indications d'application
-
- Applications: Quality tested applications include - ELISA ,
- Other referenced applications include - IHC-PS , IHC-FS , ICC , EM , WB
- Working Dilutions: ELISA BIOT conjugate 1:1,000 - 1:4,000
- Volume d'échantillon
- 0,5 mL
- Restrictions
- For Research Use only
-
- Concentration
- 0.4 mg/mL
- Buffer
- 0.2 mg of purified immunoglobulin in 0.5 mL of borate buffered saline, pH 8.2. No preservatives or amine-containing buffer salts added
- Agent conservateur
- Without preservative
- Conseil sur la manipulation
- Each reagent is stable for the period shown on the bottle label if stored as directed.
- Stock
- 4 °C
- Stockage commentaire
- Store at 2-8°C
-
-
Targeting a therapeutic LIF transgene to muscle via the immune system ameliorates muscular dystrophy." dans: Nature communications, Vol. 10, Issue 1, pp. 2788, (2019) (PubMed).
: "A missense mutation in MYH1 is associated with susceptibility to immune-mediated myositis in Quarter Horses." dans: Skeletal muscle, Vol. 8, Issue 1, pp. 7, (2018) (PubMed).
: "α3 Chains of type V collagen regulate breast tumour growth via glypican-1." dans: Nature communications, Vol. 8, pp. 14351, (2018) (PubMed).
: "
-
Targeting a therapeutic LIF transgene to muscle via the immune system ameliorates muscular dystrophy." dans: Nature communications, Vol. 10, Issue 1, pp. 2788, (2019) (PubMed).
-
- Antigène
- Collagen Type V (COL5) (Collagen, Type V (COL5))
- Autre désignation
- Type V Collagen (COL5 Produits)
-